- Acquired by Barak Investment House, Mar 2024
- Raised $6.2M PIPE led by Assi Rotbart, Apr 2020
- Raised $3.1M Follow-on PO led by Boiron, Sep 2019
About
Panaxia Pharmaceutical Industries specializes in the research, development, and manufacturing of medical cannabis. The company's goal is to align medical cannabis with formulation technologies and the highest available pharmaceutical standards. Panaxia currently manufactures a variety of standardized medical cannabis products including sublingual and oral tablets, metered-dose inhalers, creams, and suppositories. The company's products, manufacturing facility, and production processes are subject to stringent quality assurance procedures. Panaxia is part of the Panaxia Medical Devices and Pharmaceuticals Group. Panaxia's R&D center is located in Israel and is managed by senior scientists and graduates of the Weizmann Institute of Science. Panaxia offers more than 600 medical products in over 30 international markets to treat a wide range of symptoms and conditions.
Funding history · 2 rounds · $9.3M total
Headcount over time
Offices
Q&A
- What is Panaxia's primary business?
- Panaxia Pharmaceutical Industries specializes in the research, development, and manufacturing of medical cannabis products, including sublingual and oral tablets, metered-dose inhalers, creams, and suppositories.
- When was Panaxia acquired and by whom?
- Panaxia was acquired by Barak Investment House in March 2024.
- What was Panaxia's last known funding round?
- Panaxia's last funding round was in January 2024, raising $270,000.
- Who are the founders of Panaxia?
- Dadi Segal is a Co-founder and CEO of Panaxia.
- In which countries does Panaxia offer its medical products?
- Panaxia offers its medical products in over 30 international markets, including France, Greece, Israel, Poland, Malta, Portugal, Australia, Germany, and Cyprus.
- What is the total amount of funding Panaxia has raised to date?
- Panaxia has raised a total of $11,598,700.
- What is the primary sector of Panaxia?
- Panaxia's primary sector is Health Tech & Life Sciences.
Team · 11
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | panaxia.co.il |
|---|---|
| linkedin.com/company/13211586 | |
| YouTube | youtube.com/channel/UCXgmFMQ71xgbn_uQXW_4AGg |
| Wikipedia | en.wikipedia.org/wiki/Panaxia |
| Wikidata | wikidata.org/wiki/Q108057168 |
Identifiers & details
| Legal name | Panaxia Pharmaceutical Industries Ltd. |
|---|---|
| Founded | 2009-9 |
| Employees (exact) | 51 |
| Status reason | Acquired by Barak Investment House on Mar, 2024 |
| Wikidata QID | Q108057168 |
Acquisitions & public offerings
Acquired by Barak Investment House 2024-03
Radar intelligence
Patents
| EPO | 29 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | panaxia.co.il |
|---|
Wikidata
| QID | Q108057168 |
|---|
Certificate / subdomain footprint
| Subdomains | 65 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514326206 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2009-09-16 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | המלאכה 13 לוד |